General Information
Version
1.6
Revision date
2024-07-05
Product name
Primocin
1.2.1 Relevant identified uses
Laboratory research. Only for professional use
1.2.2. Uses advised against
Not for diagnostic, therapeutic, or household use
Emergency telephone
+33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
InvivoGen Asia
e-mail address of the competent person responsible for the Safety Data Sheet
info@invivogen.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapors/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. P501 Dispose of contents/container to an approved waste disposal plant.
Other hazards
Endocrine Disruptor To our knowledge, the substance or mixture does not contain any substances >0.1% that are included in the list established in accordance with Article 59(1) for having endocrine disrupting properties. PBT and vPvB substance To our knowledge, the substance or mixture does not contain any substances >0.1% that meet the criteria for persistent, bioaccumulative and toxic or very persistent and very bioaccumulative in accordance with Annex XIII.
2.1 Classification of the substance or mixture
Respiratory sensitization (Category 1), H317 Skin sensitization (Category 1), H334
